FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-041 | 71506-041-05 | Lidocaine Hydrochloride | Lidocaine Hydrochloride | 100 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-027 | 71506-027-58 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 8 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-032 | 71506-032-58 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 32 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-025 | 71506-025-58 | Norepinephrine Bitartrate | Norepinephrine Bitartrate | 4 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-028 | 71506-028-59 | Oxytocin | Oxytocin | 30 U/500 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-055 | 71506-055-10 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 400 ug/10 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-029 | 71506-029-58 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 10 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-031 | 71506-031-51 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 400 ug/5 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-047 | 71506-047-10 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-033 | 71506-033-58 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 80 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-002 | 71506-002-58 | Phenylephrine Hydrochloride | Phenylephrine Hydrochloride | 20 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-099 | 71506-099-05 | Rocuronium Bromide | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-034 | 71506-034-05 | Succinylcholine Chloride | Succinylcholine Chloride | 100 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-079 | 71506-079-56 | Thiamine Hydrochloride | Thiamine Hydrochloride | 500 mg/100 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-037 | 71506-037-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-045 | 71506-045-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.5 g/500 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-039 | 71506-039-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 750 mg/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.75 g/500 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 2 g/500 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1 g/250 mL | 2025-2 | valid | 2026-09-18 | |
| Fresenius Kabi Compounding LLC DBA Fagron Sterile Services | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | Vancomycin Hydrochloride | 1.25 g/250 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-174 | 63037-174-25 | Phenylephrine Hydrochloride | .5 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-173 | 63037-173-25 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-155 | 63037-155-25 | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-156 | 63037-156-25 | Rocuronium Bromide | 100 mg/10 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-119 | 63037-119-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-117 | 63037-117-05 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-123 | 63037-123-25 | Ephedrine Sulfate | 50 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-125 | 63037-125-25 | Glycopyrrolate | 1 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-137 | 63037-137-25 | Ketamine Hydrochloride | 50 mg/1 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-136 | 63037-136-25 | Ketamine Hydrochloride | 50 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-164 | 63037-164-25 | Lidocaine Hydrochloride Anhydrous | 100 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 117939054 | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | 5 mg/5 mL | 2025-2 | valid | 2026-10-13 | |
| Hikma Injectables USA Inc. | 63037-119 | 63037-119-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-117 | 63037-117-05 | Diltiazem HCl | Diltiazem HCl | 125 mg/125 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-123 | 63037-123-25 | Ephedrine Sulfate | Ephedrine Sulfate | 50 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-100 | 63037-100-05 | Fentanyl Citrate in 0.9 % Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 1000 ug/100 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-101 | 63037-101-05 | Fentanyl Citrate in 0.9% Sodium Chloride | Fentanyl Citrate in 0.9% Sodium Chloride Injection | 2500 ug/250 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-125 | 63037-125-25 | Glycopyrrolate | Glycopyrrolate | 1 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-137 | 63037-137-25 | Ketamine HCl | Ketamine HCl | 50 mg/1 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-136 | 63037-136-25 | Ketamine HCl | Ketamine HCl | 50 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-164 | 63037-164-25 | Lidocaine HCl | Lidocaine HCl 2% | 100 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-139 | 63037-139-25 | Neostigmine Methylsulfate | Neostigmine Methylsulfate | 5 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-174 | 63037-174-25 | Phenylephrine HCl | Phenylephrine HCl | .5 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-173 | 63037-173-25 | Phenylephrine HCl | Phenylephrine HCl | 1 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-156 | 63037-156-25 | Rocuronium Bromide | Rocuronium Bromide | 100 mg/10 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Injectables USA Inc. | 63037-155 | 63037-155-25 | Rocuronium Bromide | Rocuronium Bromide | 50 mg/5 mL | 2025-2 | valid | 2026-09-18 | |
| Hikma Pharmaceuticals USA Inc. | 946499746 | 63037-101 | 63037-101-05 | Fentanyl Citrate | 2500 ug/250 mL | 2025-2 | valid | 2026-10-13 |